Pulmatrix Inc (PULM)

[riskon]

$PULM -- potentially troubling recent earnings report showing only $8M cash on hand, with a cash burn rate of $6M, when they filed an S1 for up to $57M and investors presentations said they raised enough money to fund through Q4 2019. Recently just created a clinical advisory board of directors for their Pur1900 study which is patented QEDP rights through 2031.

They also paid a loan on $3M, of which one of the clauses in the loan was it could not be outstanding if a merger or acquisition was to take place.

Hmmm...